Director, CMC
Dow Development Labs, LLC
Mr. Carbol has over twenty years of industry experience in the development of topical products. He currently holds the title of CMC Director at Dow Development Laboratories (DDL), a CDMO specializing in the development, manufacture and testing of topicals. Mr. Carbol’s responsibilities include strategic formulation design of Rx topical products using QbD principles and Design of Experiments tools, in addition to process development, scale up and tech transfer. In his work with large and small companies, Mr. Carbol has worked with dozens of active pharmaceutical ingredients in a wide variety of topical dosage forms, such as creams, gels, ointments, and sprays. He has supported multiple IND, NDA and ANDA filings. Overall, he has successfully developed and scaled up over 35 topical drug products, many to commercial scale, including generic products for ANDA submission and approval as well as new products containing new chemical entities for IND and NDA submission and approval.